Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa F-P Ng

Showing results (121-130 of 165) with videos related to

Pageof 17
Sort By:
Frontiers in Microbiology|December 9, 2022
Conserved longitudinal alterations of anti-S-protein IgG subclasses in disease progression in initial ancestral Wuhan and vaccine breakthrough Delta infectionsYun Shan Goh, Siew-Wai Fong, Pei Xiang Hor, et al.
The Journal of Infectious Diseases|March 23, 2019
ZIKV-Specific NS1 Epitopes as Serological Markers of Acute Zika Virus InfectionYiu-Wing Kam, Juliana Almeida Leite, Siti Naqiah Amrun, et al.
Scientific Reports|November 22, 2018
Multimodal assessments of Zika virus immune pathophysiological responses in marmosetsFok-Moon Lum, Wei Zhang, Kheng-Choon Lim, et al.
NPJ Vaccines|October 26, 2021
Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in SingaporeBei Wang, Yun Shan Goh, Tessa Prince, et al.
Journal of Medical Virology|May 22, 2023
Prolonged inflammation in patients hospitalized for coronavirus disease 2019 (COVID-19) resolves 2 years after infectionSiew-Wai Fong, Yun Shan Goh, Anthony Torres-Ruesta, et al.
EMBO Molecular Medicine|December 3, 2014
Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody responseZhisheng Her, Terk-Shin Teng, Jeslin J L Tan, et al.
Scientific Reports|December 9, 2023
Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2Yue Gu, Bhuvaneshwari Shunmuganathan, Xinlei Qian, et al.
Scientific Reports|May 5, 2026
Optimizing mouse models for mRNA vaccines: addressing dose translation challengesZi Wei Chang, Yong Jie Tan, Yiyu Liao, et al.
EMBO Molecular Medicine|March 6, 2012
Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoproteinYiu-Wing Kam, Fok-Moon Lum, Teck-Hui Teo, et al.
The Journal of Infectious Diseases|April 20, 2018
Longitudinal Study of Cellular and Systemic Cytokine Signatures to Define the Dynamics of a Balanced Immune Environment During Disease Manifestation in Zika Virus-Infected PatientsFok-Moon Lum, David C B Lye, Jeslin J L Tan, et al.
Pageof 17

Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
Frontiers in Microbiology|December 9, 2022
Conserved longitudinal alterations of anti-S-protein IgG subclasses in disease progression in initial ancestral Wuhan and vaccine breakthrough Delta infectionsYun Shan Goh, Siew-Wai Fong, Pei Xiang Hor, et al.
The Journal of Infectious Diseases|March 23, 2019
ZIKV-Specific NS1 Epitopes as Serological Markers of Acute Zika Virus InfectionYiu-Wing Kam, Juliana Almeida Leite, Siti Naqiah Amrun, et al.
Scientific Reports|November 22, 2018
Multimodal assessments of Zika virus immune pathophysiological responses in marmosetsFok-Moon Lum, Wei Zhang, Kheng-Choon Lim, et al.
NPJ Vaccines|October 26, 2021
Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in SingaporeBei Wang, Yun Shan Goh, Tessa Prince, et al.
Journal of Medical Virology|May 22, 2023
Prolonged inflammation in patients hospitalized for coronavirus disease 2019 (COVID-19) resolves 2 years after infectionSiew-Wai Fong, Yun Shan Goh, Anthony Torres-Ruesta, et al.
EMBO Molecular Medicine|December 3, 2014
Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody responseZhisheng Her, Terk-Shin Teng, Jeslin J L Tan, et al.
Scientific Reports|December 9, 2023
Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2Yue Gu, Bhuvaneshwari Shunmuganathan, Xinlei Qian, et al.
Scientific Reports|May 5, 2026
Optimizing mouse models for mRNA vaccines: addressing dose translation challengesZi Wei Chang, Yong Jie Tan, Yiyu Liao, et al.
EMBO Molecular Medicine|March 6, 2012
Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoproteinYiu-Wing Kam, Fok-Moon Lum, Teck-Hui Teo, et al.
The Journal of Infectious Diseases|April 20, 2018
Longitudinal Study of Cellular and Systemic Cytokine Signatures to Define the Dynamics of a Balanced Immune Environment During Disease Manifestation in Zika Virus-Infected PatientsFok-Moon Lum, David C B Lye, Jeslin J L Tan, et al.
Pageof 17